(Q57384572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Martin R. Sprick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Klaus-Michael Debatin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

7

Büchler MW

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Wenger T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Mattern J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Walczak H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Herr I

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

22 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

316-326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701016

23 December 2019

exact match

0 references

cites work

Nature's TRAIL--on a path to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Clinical development of gene therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Gene therapy for human malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Strategies for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Lentiviral vectors: turning a deadly foe into a therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Harnessing HIV for therapy, basic research and biotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Retroviral membrane display of apoptotic effector molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLCin vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

inferred from DOI database lookup

7 January 2021

based on heuristic

Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701016

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7701016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17186015%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference